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Abstract
We studied and performed genetic linkage studies and mutational analysis on 1 1 patients from
5 unrelated kindreds with Andersen's syndrome (AS). Our data suggest AS is a distinct
periodic paralysis occurring in the setting of either hyper- or hypokalemia, with severe cardiac
involvement (LQT) and distinct skeletal abnormalities whose gene defect is still unknown.
Key words: Andersen's syndrome, periodic paralysis, channelopathy, myopathy, LQTS.
Basic Appl Myol 7 (5): 329-331, 1997
The periodic paralysis and the non-dystrophic myo-
tonias are a group of hereditary myopathies that share the
common phenotype of episodic muscle weakness or pa-
ralysis in the absence of abnormalities of the motor nerve,
neuromuscular junction or contractile proteins [14]. A
hallmark of these disorders is the acute depolarization of
the sarcolemma that accompanies the paralytic episodes,
usually sparing the cardiac and respiratory muscles.
Genetic linkage studies and mutational analysis have
identified 3 chromosomes responsible for 3 different
groups of periodic paralysis, each involving a different
channel protein. The sodium-channelopathies are linked to
chromosome 17q and include hyperkalemic periodic pa-
ralysis (in which attacks of weakness occur in the setting
of increased serum levels of potassium), paramyotonia
congenita (in which attacks are precipitated by cold), and
potassium-aggravated myotonias, including the acetazo-
lamide-sensitive periodic paralysis [5, 20, 21], PAM (in
which myotonia is precipitated by a spontaneous rise in
serum potassium levels). This condition has also been
called myotonia fluctuans because of the fluctuating nature
of symptoms. The calcium-channelopathies are linked to
chromosome Iq and refer to hypokalemic periodic paraly-
sis, in which attacks of weakness occur in the setting of
decrease serum levels of potassium, usually precipitated
by a carbohydrate-rich meal [22]. The chloride-chan-
nelopathies are linked to chromosome 7q and refer to both
autosomal and recessive forms of myotonia congenita [9,
10]. Although a potassium channel has been identified in
a group of hereditary ataxias [4], therefore disorders of the
central nervous system, none of the periodic paralysis or
the non-dystrophic myotonias has yet been linked to the
adult skeletal muscle potassium channel.
In periodic paralysis, onset of weakness is often diag-
nosed by the patient, after the first attack and some meas-
ures can be used to abort the attack. When weakness
develops, all 4 limbs may be affected to the extent that the
patient is unable to move or lift one arm or leg from the
bed. The attack may last from several hours to days.
Different events, foods, drugs or other factors have been
identified so far in triggering the attacks of weakness.
Individuals with periodic paralysis often appear normal
between attacks, and do not complain of persistent muscle
weakness and pain between attacks. However, in some
variants a fixed weakness with a persistent myopathy can
eventually develop [14]. In patients with hypokalemic
periodic paralysis, repeated attacks of paralysis often give
rise to persistent proximal weakness involving the lower
limbs especially, generally not associated with significant
muscle atrophy. The frequency of attacks might be wors-
ened by the treatment of the disorder with oral potassium.
On CT scans, weakness in the limbs correlates to abnor-
mally high amounts of fat and connective tissue within the
affected muscle groups [15].
Although the acute depolarization of the sarcolemma
that occurs in periodic paralysis generally spares the car-
diac and respiratory muscle membranes, in some forms of
periodic paralysis, cardiac dysrhythmias are a primary
manifestation of the disease, independent of serum potas-
sium levels. Table 1 summarizes most of the reported cases
so far. In most cases the familial nature of the disorder was
clear and the cardiac involvement was severe, sometimes
fatal, always involving ventricular dysrhythmias and inde-
pendent of the serum potassium levels [6, 7, 8, 11, 16, 17,
18, 24]. Of the reported cases of periodic paralysis with
cardiac involvement, Andersen described in 1971 a boy
with attacks of muscle weakness, severe cardiac involve-
ment and dysmorphic features and, although unable to
identify the disorder amongst others described to that date,
recognized the possibility of a new syndrome [1 ]. In 1994,
Tawil et al described 4 patients with hyperkalemic periodic
paralysis, ventricular arrhythmias and similar dysmorphic
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Table 1. Periodic paralysis with cardiac involvement.
PERIODIC VENTRICULAR
PARALYSIS TACHYCARDIA
Klein etal. 1963
Andersen etal. 1971
Levitt etal. 1972
Lisaketal. 1972
Stubbsetal. 1976
Kramer etal. 1979
Yoshimura et al. 1983
Gould et al. 1985
Fukudaetal. 1988
Baqueroetal. 1995
HypoKPP
normoKPP
HypoKPP
normoKPP
hypoKPP
hypoKPP
normoKPP
hyperKPP?
?
hyperKPP?
+
+
+
+
+
sinus arrhythmia
+
+
+
+
features to the boy described by Andersen and coined the
term Andersen's syndrome (AS) [22]. Genetic linkage
studies excluded chromosome 17 in these patients and the
syndrome appeared distinct from a clinical and genetic
point of view to previously reported periodic paralyses.
Materials and Methods
We report on 11 patients from 5 unrelated AS kindreds.
All patients underwent detailed clinical and neurologic
examination. Careful study of the type of paralysis that
occurred, the triggering factors, precipitating events, dura-
tion of the attack was undertaken. The patients were given
a special form to fill in on the characteristics of the attack
when this occurred. When the type of attack that occurred
was unclear and not confirmed by the decrease or increase
of serum potassium levels, hypokalemic and hyperkalemic
challenges were done according to standard protocols. In
some cases, muscle biopsy was done to assess the degree
of muscle involvement. All patients had EMG studies, to
look for myotonia according to standard protocols, includ-
ing the exercise test [19].
For genetic studies [22], in two three-generation kin-
dreds we used markers tightly linked to the hyperkalemic
periodic paralysis gene [20] and four long QT syndrome
loci (LQT 1-4) [23]. Linkage to the LQT loci was looked
for because 10 of 1 1 patients had a prolonged QT interval
and also because this was the only manifestation of the
syndrome in family members of typical AS kindreds.
Kindreds were not large enough to perform linkage analy-
sis to the calcium channel gene but mutational analysis was
carried out for possible mutations as previously described
[21].
Clinical overview
A clear autosomal dominant pattern of inheritance was
present in 10 of 11 patients. The patients' age ranged from
8 to 87 years and cardiac symptoms, when present, usually
preceded the onset of muscle symptoms. Cardiac symp-
toms at onset usually included syncopes with cardiac arrest
or bouts of symptomatic ventricular tachycardias. Onset of
muscle symptoms was with an episode of periodic paraly-
sis, without pain and not always triggered by a known
event or precipitating factor. In some patients the attacks
of weakness had been undiagnosed until the onset of the
more severe cardiac symptoms. In most cases of severe
paralysis, serum potassium was determined during the
attacks and in two patients spontaneous attacks occurred
in the setting of clear hypokalemia, in two others in hy-
perkalemia and in the remaining patients in normokalemia.
Challenges were not performed in all patients because of
the severity of the cardiac symptoms present. All probands
had a definite interattack proximal weakness suggesting a
limb-girdle type myopathy, in the absence of significant
atrophic changes and with only mildly decreased tendon
reflexes. The clinical diagnosis of persistent myopathy was
confirmed by the presence of tubular aggregates in the
muscle biopsies. Clinical, percussion, lingual or EMG
myotonia was absent in all patients, including the ones with
the hyperkalemic form of periodic paralysis. In most pa-
tients there were no signs of central nervous system in-
volvement except for mild psychomotor delay in one
patient in whom tendon reflexes and a Babinski sign were
present. Brain and spinal cord MRI were normal in this
patient.
Cardiac involvement varied from the presence of a pro-
longed QT interval in the absence of clinical symptoms in
grandparents to the severe bidirectional ventricular tachy-
cardia and cardiac arrest in the probands. The prolonged
QT interval was often an isolated finding in otherwise
typical AS kindreds. Three patients required a pace-maker
and the remaining were on other class 1 anti-arrhythmic
drugs with careful control of their ECG and serum potas-
sium levels because of a potential worsening of their
arrhythmia during the treatment itself or worsening of the
periodic paralysis.
None of the patients had the severe dysmorphic features
described by Andersen in the original article, but all had
recurrent distinct skeletal and facial features. Often it was
the distinctive facial appearance that suggested the diag-
nosis of AS compared to other forms of periodic paralysis
or to other causes of sudden weakness. Most patients were
short and small for age, usually with small or protruded
chin (micrognathia), low-set ears, broad nose, short neck,
and excessively set apart eyes (hypertelorism). All had
clinodactyly or syndactyly of the fingers of the hands or
feet, and this was a feature in the parents and grandparents
of the probands as an isolated feature together with the
prolonged QT.
From a genetic point of view, three families were large
enough to test the hypothesis that AS might be allelic with
long QT syndrome. However, linkage to the four long QT
loci was excluded. Linkage analysis had previously ex-
cluded linkage of AS to the hyperkalemic periodic paraly-
sis locus on chromosome 17. Linkage studies in the present
kindreds confirm these observations. In addition, muta-
tional analysis excluded, common hypokalemic periodic
paralysis mutations in the dihydropyridine receptor gene.
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Conclusion
AS is a distinct periodic paralysis occurring in the setting
of hypo-, hyper- or normokalemia [12] in the presence of
severe cardiac involvement, independent of serum potas-
sium levels. In addition to the cardiac and muscle symp-
toms, there are constant and distinct facial and skeletal
features, often the clue to the diagnosis of this periodic
paralysis. The finding of the triad of periodic paralysis,
long QT interval and the distinct skeletal and facial fea-
tures suggests a syndrome, although the genetic defect is
still unknown. The recent description of a case of periodic
paralysis with cardiac arrhythmia associated with a sodium
channel mutation, with no evidence of skeletal or facial
distinctive features, suggests that there exist syndromes of
periodic paralysis with cardiac involvement distinct from
AS [2].
Andersen's syndrome does not respect the conventional
classification of the periodic paralysis on the basis of
variations in serum potassium levels because the attacks of
paralysis may occur with decrease or increase according
to the type of periodic paralysis associated in the AS
syndrome in that particular kindred. It is not unexpected
therefore that linkage to the known sodium, calcium or
chloride channel genes was excluded. In the prototypical
heart-hand syndrome (Holt-Oram syndrome), the complex
phenotype is the result of a single-gene mutation so that
this hypothesis cannot be ruled out in AS also [3]. Alter-
natively, the genetic lesion could involve more than one
gene explaining the coexistence of abnormalities of car-
diac and skeletal muscle membrane excitability and at the
same time accounting for the characteristic physical find-
ings. Patch-clamp studies in the Schwartz-Jampel syn-
drome, a disorder similar to AS in combining abnormal
skeletal muscle membrane excitability with distinctive
skeletal features, demonstrated abnormalities in multiple
channels suggesting a multiple-gene disorder [13].
In conclusion the diagnosis of AS is made on the finding
of autosomal dominant inheritance of periodic paralysis,
ventricular arrhythmia, especially LQT and distinctive
facial and skeletal features. This implies that a cardiac
screening should be done in all patients with periodic
paralysis, regardless of cardiac symptoms. Although the
full clinical syndrome includes the triad described above,
partial manifestations of the syndrome are common in
family members of patients with the full AS triad, often
with a prolonged QR as the minimal manifestation. AS
should be considered in the differential diagnosis of LQT
syndromes especially in the presence of distinctive physi-
cal features.
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